New book by Larry Connors Click here Improve your trading - See how
The seminar is part of a conference for Minimally Invasive and Digital Dentistry being hosted by the American Society for Clinical Research and the Academy of General Dentistry. More than 500 dentists from across the country and around the world are expected to attend the conference. Den-Mat is the world's largest producer of dental veneers and the leading sponsor of the conference.
The FirstFit presentation will be conducted by Remedent's CEO, Guy De Vreese, on Saturday, November 7, with the Belgian inventor of FirstFit, Dr. Evelyne Jacquemyns, presenting live via Web cast from one of Remedent's international GlamSmile locations in Dubai, UAE. The event represents the first official presentation of the new bridge and crown technology to dentists in the United States since FirstFit's international introduction in June of this year.
The FirstFit system requires no temporary placements, creates less mouth trauma and takes fewer office visits to complete. With economic benefits for both patients and dentists, the new technology addresses an expanding U.S. market for dental crowns and bridges, and has the potential to change the way modern dentistry is practiced.
"This presentation of FirstFit builds upon the success of our dental veneer technology which Den-Mat markets as LUMITRAY(R)," said Guy De Vreese, CEO of Remedent. "We expect the rollout of FirstFit, with Den-Mat's assistance, will significantly expand our presence in the North American professional dental market. We greatly value Den-Mat's substantial commitment of resources to FirstFit as we introduce the many revolutionary features and benefits the new technology offers both dentists and the consumer."
The three day event will also feature demonstrations of the LUMITRAY veneer placement system that creates attractive, confident, life-changing smiles without full-prep. LUMITRAY is also the only veneer placement system that makes possible the placing of a full arch in one motion.
More information about the event is available on the American Society for Clinical Research Web site at www.ascredu.org/three-day-seminars.html.
About Den-Mat Holdings, LLC
California-based Den-Mat Holdings, LLC is a leading manufacturer and marketer of advanced cosmetic and restorative dental products and laboratory services that allow a dentist to preserve, restore and enhance their patient's teeth typically without the requirement for anesthesia, extensive cutting, drilling and tooth removal. This revolutionary type of dentistry not only focuses on superior aesthetic results, but on patient comfort and convenience as well. Den-Mat's revolutionary LUMINEERS(R) BY CERINATE(R) are porcelain veneers that offer a painless way to a permanently whiter and perfectly aligned smile. LUMINEERS are the only porcelain laminates that are strong, reversible, and have a proven record of over 20 years of clinical success. The dentist applies these contact lens-thin veneers to teeth without the need for the shaving and grinding down of sensitive tooth structure that is common with traditional veneers. Den-Mat is a unit of DLJ Merchant Banking Partners, a private equity investment affiliate of Credit Suisse. For additional information, visit www.denmat.com.
About Credit Suisse
As one of the world's leading banks, Credit Suisse provides its clients with investment banking, private banking and asset management services worldwide. Credit Suisse offers advisory services, comprehensive solutions and innovative products to companies, institutional clients and high-net worth private clients globally, as well as retail clients in Switzerland. Credit Suisse is active in over 50 countries and employs approximately 40,000 people. Credit Suisse's parent company, Credit Suisse Group, is a leading global financial services company headquartered in Zurich. Credit Suisse Group's registered shares (CSGN) are listed in Switzerland and, in the form of American Depositary Shares (CS), in New York. Further information about Credit Suisse can be found at www.creditsuisse.com.
About Remedent
Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves the professional dental industry with breakthrough technology for dental veneers, bridges and crowns which are recognized worldwide for their technological superiority and ease-of-application. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 35 countries worldwide. For more information, go to www.rememdent.com.
Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors because of such risks and uncertainties. The agreement with Den-Mat for FirstFit is subject to satisfaction or waiver of certain closing conditions which includes, in addition to customary closing conditions, due diligence completed to Den-Mat's satisfaction with respect to the FirstFit products; delivery of legal opinion and certain executed non-competition agreements; and delivery of the development payment and first installment of the license payment. For further information regarding risks and uncertainties associated with company's business, please refer to the risk factors described in the Company's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q.
Company Contacts: Stephen Ross Chief Financial Officer Remedent, Inc. Tel (310) 922-5685 Email Contact Investor Relations: Ron Both Managing Director Liolios Group, Inc. Tel (949) 574-3860 Email Contact
SOURCE: Remedent, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=ED4A81EEE9AA4D48 http://www2.marketwire.com/mw/emailprcntct?id=82DC0AAD52819123
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
